Equity Research Associate – MedTech

Piper Sandler•New York, NY

4d•$80,000 - $125,000•Onsite

About The Position

Piper Sandler is seeking an Equity Research Associate to join their Healthcare - MedTech group in their New York, NY office. The role involves supporting senior analysts in conducting research, creating financial models, writing reports, and developing investment recommendations. As associates gain expertise, they will also be responsible for marketing research and recommendations to the sales force and institutional investors. Piper Sandler emphasizes a culture that connects capital with opportunity, fosters innovation through diverse teams, and supports employee well-being.

Requirements

1-3 years of Equity Research or Investment Banking experience.
Ability to thrive in a demanding and fast-paced environment that requires the ability to think quickly on one's feet and work independently.
A strong interest in the stock market and a demonstrated record of professional, academic and personal achievement.
Outstanding interpersonal and written communication skills.
Outstanding quantitative and organizational skills.
A strong competitive spirit balanced by a proven ability to work as part of a team.
Bachelor’s degree in Accounting, Finance, Economics, Electrical Engineering or related degrees required.
Strong financial modeling experience required.
Strong interest in Healthcare, specifically the MedTech space.
Securities Industry Essentials, Series 86 and 87 required (or willingness to obtain).

Nice To Haves

Progress towards CFA a plus.

Responsibilities

Conduct extensive company and industry research in partnership with the senior analyst.
Create financial models and valuation analyses.
Write company reports, industry reports, and develop investment recommendations.
Form relationships with company management teams through meetings, calls, roadshows, etc.
Make company visits and attend industry conferences.
Market the team's research and investment recommendations to the sales force and institutional investors.